Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 10 results

Author Title Type [ Year

]

Filters: Author is Hayes, P [Clear All Filters]

2015

Omosa-Manyonyi, G, J Mpendo, E Ruzagira, W Kilembe, E Chomba, F Roman, P Bourguignon, et al.. 2015. “A Phase I Double Blind, Placebo-Controlled, Randomized Study Of The Safety And Immunogenicity Of An Adjuvanted Hiv-1 Gag-Pol-Nef Fusion Protein And Adenovirus 35 Gag-Rt-Int-Nef Vaccine In Healthy Hiv-Uninfected African Adults”. Plos One 10. Plos One: e0125954. http://www.ncbi.nlm.nih.gov/pubmed/25961283.

2014

Hayes, P, N Fernandez, G Omosa-Manyonyi, J Mpendo, E Karita, E Ruzagira, W Kilembe, et al.. 2014. “Assessment Of Viral Inhibition Activity In Low Seroprevalent Adenovirus-35 Vectored Hiv Vaccines +/- Adjuvanted Protein Or Electroporated Dna”. In Hiv Research For Prevention 2014: Aids Vaccine, Microbicide And Arv-Based Prevention Science (Hivr4P). Hiv Research For Prevention 2014: Aids Vaccine, Microbicide And Arv-Based Prevention Science (Hivr4P). Cape Town, SA. http://hivr4p.org/.

2012

Keefer, M, J Gilmour, P Hayes, D Gill, J Kopycinski, H Cheeseman, M Cashin-Cox, et al.. 2012. “A Phase I Double Blind, Placebo-Controlled, Randomized Study Of A Multigenic Hiv-1 Adenovirus Subtype 35 Vector Vaccine In Healthy Uninfected Adults”. Plos One 7. Plos One: e41936. http://www.ncbi.nlm.nih.gov/pubmed/22870265.

2010

Vardas, E, P Kaleebu, L Bekker, A Hoosen, E Chomba, P Johnson, P Anklesaria, et al.. 2010. “A Phase 2 Study To Evaluate The Safety And Immunogenicity Of A Recombinant Hiv Type 1 Vaccine Based On Adeno-Associated Virus”. Aids Res Hum Retroviruses 26. Aids Res Hum Retroviruses: 933-942. http://www.ncbi.nlm.nih.gov/pubmed/20666584.

Jaoko, W, E Karita, K Kayitenkore, G Omosa-Manyonyi, S Allen, S Than, E Adams, et al.. 2010. “Safety And Immunogenicity Study Of Multiclade Hiv-1 Adeno-Viral Vector Vaccine Alone Or As Boost Following A Multiclade Hiv-1 Dna Vaccine In Africa”. Plos One 5. Plos One: e12873. http://www.ncbi.nlm.nih.gov/pubmed/20877623.

Spentzou, A, P Bergin, D Gill, H Cheeseman, A Ashraf, H Kaltsidis, M Cashin-Cox, et al.. 2010. “Viral Inhibition Assay: A Cd8 T Cell Neutralization Assay For Use In Clinical Trials Of Human Immunodeficiency Virus-1 Vaccine Candidates”. J Infect Dis 201. J Infect Dis: 720-729. http://www.ncbi.nlm.nih.gov/pubmed/20132004.

2008

Guimarães-Walker, A, N Mackie, S McCormack, T Hanke, C Schmidt, J Gilmour, B Barin, et al.. 2008. “Lessons From Iavi-006, A Phase I Clinical Trial To Evaluate The Safety And Immunogenicity Of The Pthr.hiva Dna And Mva.hiva Vaccines In A Prime-Boost Strategy To Induce Hiv-1 Specific T-Cell Responses In Healthy Volunteers.”. Vaccine 26 (51). Vaccine: 6671-7. doi:10.1016/j.vaccine.2008.09.016.

2006

Goonetilleke, N, S Moore, L Dally, N Winstone, I Cebere, A Mahmoud, S Pinheiro, et al.. 2006. “Induction Of Multifunctional Human Immunodeficiency Virus Type 1 (Hiv-1)-Specific T Cells Capable Of Proliferation In Healthy Subjects By Using A Prime-Boost Regimen Of Dna-And Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing [..] Epitopes”. J Virol 80. J Virol: 4717-4728. http://www.ncbi.nlm.nih.gov/pubmed/16641265.

2005

Peters, B, W Jaoko, O Anzala, L Judges, Omosa G Manyonyi, A Sharp, K Gray, et al.. 2005. “Phase 2A Dose And Route Study Of A Dna Prime Mva Boost Vaccine Candidate”. In Aids Vaccine 2005 International Conference. Aids Vaccine 2005 International Conference. Montreal, Quebec, Canada.

2004

Guimarães-Walker, A, N Mackie, A McMichael, J Weber, S McCormack, I Cebere, R Kay, et al.. 2004. “Priming With A Candidate Hiv-1 Clade A Dna Vaccine Followed By Boosting With An Hiv-1 Clade A Mva Vaccine In Volunteers At Low Risk Of Hiv Infection”.